Urinary CD80 levels as a diagnostic biomarker of minimal change disease

Serum-soluble urokinase receptor levels do not distinguish focal segmental glomerulosclerosis from other causes of nephrotic syndrome in children

(2014) Aditi Sinha et al.   KIDNEY INTERNATIONAL

Co-stimulatory molecules as targets for treatment of lupus

(2013) Joan T. Merrill   CLINICAL IMMUNOLOGY

Safety of paediatric percutaneous native kidney biopsy and factors predicting bleeding complications

(2013) Pornpimol Rianthavorn et al.   NEPHROLOGY

CD80 and suPAR in patients with minimal change disease and focal segmental glomerulosclerosis: diagnostic and pathogenic significance

(2013) Gabriel Cara-Fuentes et al.   PEDIATRIC NEPHROLOGY

Focal Segmental Glomerulosclerosis

(2011) Vivette D. D'Agati et al.   NEW ENGLAND JOURNAL OF MEDICINE

Maximal ‘CD80-uria’ with minimal change

(2010) Andreas D. Kistler et al.   KIDNEY INTERNATIONAL

Urinary CD80 is elevated in minimal change disease but not in focal segmental glomerulosclerosis

(2010) Eduardo H. Garin et al.   KIDNEY INTERNATIONAL

Minimal change disease: a “two-hit” podocyte immune disorder?

(2010) Michiko Shimada et al.   PEDIATRIC NEPHROLOGY

Urinary CD80 Excretion Increases in Idiopathic Minimal-Change Disease

(2008) E. H. Garin et al.   JOURNAL OF THE AMERICAN SOCIETY OF NEPHROLOGY